It is well known that cocaine blocks the dopamine transporter. This mechanism should lead to a general increase in dopaminergic neurotransmission, and yet dopamine D 1 receptors (D 1 Rs) play a more significant role in the behavioral effects of cocaine than the other dopamine receptor subtypes. Cocaine also binds to σ-1 receptors, the physiological role of which is largely unknown. In the present study, D 1 R and σ 1 R were found to heteromerize in transfected cells, where cocaine robustly potentiated D 1 R-mediated adenylyl cyclase activation, induced MAPK activation per se and counteracted MAPK activation induced by D 1 R stimulation in a dopamine transporterindependent and σ 1 R-dependent manner. Some of these effects were also demonstrated in murine striatal slices and were absent in σ 1 R KO mice, providing evidence for the existence of σ 1 R-D 1 R heteromers in the brain. Therefore, these results provide a molecular explanation for which D 1 R plays a more significant role in the behavioral effects of cocaine, through σ 1 R-D 1 R heteromerization, and provide a unique perspective toward understanding the molecular basis of cocaine addiction.
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receptor heteromer | drug addiction A key molecular mechanism contributing to the development of addiction by drugs of abuse consist of the increase of the extracellular levels of dopamine in the striatum, particularly in its ventral portion, the nucleus accumbens (1, 2) . Cocaine causes a rapid and strong increase in striatal extracellular dopamine by its ability to bind with high affinity to the dopamine transporter (DAT) and to inhibit its function (3) (4) (5) . In the striatum, dopamine signaling is mediated mainly by dopamine D 1 and D 2 receptors (D 1 Rs and D 2 Rs, respectively), which are mostly segregated in two phenotypically different subtypes of GABAergic medium-sized spiny neurons (MSNs) (6) . Activation of D 1 Rs is an absolute requirement for the induction of many of the cellular and behavioral responses to cocaine, as deduced from studies performed in D 1 R KO mice and from experiments with transgenic mice in which D 1 R-or D 2 R-expressing MSNs are visualized by the expression of fluorescent proteins (7) (8) (9) (10) (11) .
The σ-1 receptor, originally proposed as a subtype of opioid receptors, is now considered to be a nonopioid receptor with two transmembrane domains, one extracellular loop and cytosolic N and C termini (12) . The σ 1 R is highly expressed in the brain, including the striatum, and its association with neurons is well established (12, 13) . However, its biological function and even its main endogenous neurotransmitter remain enigmatic (12) . Cocaine interacts with σ 1 Rs at pharmacologically relevant concentrations (12, 14) . In fact, reducing brain σ 1 R levels with antisense oligonucleotides attenuates the convulsive and locomotor stimulant actions of cocaine (15, 16) , and σ 1 R antagonists mitigate the actions of cocaine in animal models (12, 14) . A recent study showed that σ 1 R agonists not only potentiate the reinforcing effects of cocaine, but they may be self-administered (17) . In the current study, we explored the existence of molecular and functional interactions between σ 1 R and D 1 R, which could underlie these pharmacological interactions.
Using bioluminescence resonance energy transfer-based techniques, we report a molecular interaction in living cells between σ 1 R and D 1 R. Cocaine was able to bind to a receptor heteromer constituted by at least one σ 1 R and two D 1 R units and promoted structural changes in the heteromer that led to significant modifications in D 1 R function. Cocaine effects on D 1 R function did not occur in cells transfected with σ 1 R siRNA or in striatal slices of σ 1 R KO mice. Altogether, the findings indicate that σ 1 R-D 1 R heteromer-mediated alterations of dopaminergic neurotransmission constitutes a previously uncharacterized mechanism of cocaine action.
Results
Heteromerization of σ 1 R and D 1 R. We explored the possibility that σ 1 R might interact directly with D 1 R. BRET measurements were performed in HEK-293T cells expressing a constant amount of D 1 R fused to Renilla Luciferase (Rluc) and increasing amounts of σ 1 R fused to yellow fluorescence protein (YFP). A positive and saturable BRET signal was obtained (BRET max , 44 ± 4; BRET 50 , 18 ± 3; Fig. 1A ). The pair constituted by the adenosine A 1 receptor fused to Rluc, and the σ 1 R-YFP was used as a negative control. As shown in Fig. 1A , the negative control gave a linear nonspecific BRET signal, thus confirming the specificity of the interaction between D 1 R-Rluc and σ 1 R-YFP. Because one of the limitations of BRET is that it cannot distinguish between two or three interacting proteins, and because homomerization seems to be a requirement for the normal membrane expression of D 1 R (18), we investigated the possible formation of receptor heteromers constituted by σ 1 R and D 1 R homomers by combining BRET with bimolecular fluorescence complementation (BiFC, Fig.1C ) (19) . interact with D 1 R homodimers (Fig. 1B) . Collectively, these results indicate that σ 1 R-D 1 R heteromers occur in cells coexpressing both receptors.
Cocaine Induces Modifications of Subcellular Distribution of σ 1 R. It is known that the majority of σ 1 R are found in the endoplasmic reticulum membrane (12) . The possibility that cocaine binding to the σ 1 R may alter the cell surface levels of putative σ 1 R-D 1 R heteromers was therefore explored. HEK-293T cells were used in the assays, because they constitutively express σ 1 R, but not DAT ( Fig. 2 A and B) . By means of immunofluorescence a punctate σ 1 R staining in naïve HEK cells was detected, which is the expected pattern for an endoplasmic reticulum-associated protein (Fig. 2C , Left, top images). Expression of D 1 R induced in HEK-293T cells an increase in the localization of σ 1 R at the plasma membrane (Fig. 2C , Left, bottom images), suggesting that heteromerization with D 1 R facilitates translocation of σ 1 R to the plasma membrane. Cocaine (150 μM; 30 min) produced an increase of σ 1 R expression at the plasma membrane in nontransfected cells (Fig. 2C , Right, top images) and an increase in the colocalization of σ 1 Rs and D 1 Rs in transfected cells (Fig. 2C , Right, bottom images), suggesting that cocaine induces an increase in the amount of σ 1 R-D 1 R heteromers at the plasma membrane. of cocaine treatment, there was no real disruption of D 1 R homomerization, because cocaine did not modify the amount of fluorescence in HEK 293 cells expressing D 1 R-cYFP-D 1 RnYFP dimers. These results strongly suggest that cocaine binding to σ 1 R alters the quaternary structure of the σ 1 R-D 1 R-D 1 R heteromer, resulting from separation of the C-termini of the D 1 R protomers fused to Rluc and YFP. The participation of σ 1 R on the cocaine-mediated alteration of the quaternary structure of D 1 R was demonstrated in experiments performed in cells the σ 1 R expression of which was knocked down using an RNAi approach. By RNA interference (RNAi), using a specific small interfering RNA (siRNA), a robust silencing of σ 1 R expression was obtained without significantly altering the expression of D 1 R (Figs. 4 A and  B) . The treatment with the specific siRNA completely abolished the effect of cocaine on the BRET saturation curve obtained with D 1 R-Rluc and D 1 R-YFP (Fig. 4C) . Finally, the selective σ 1 R agonist PRE084 also modified the BRET saturation curve corresponding to D 1 R-Rluc-D 1 R-YFP pair (200 nM; 10 min) (Fig. S1 ).
Cocaine Binding to σ 1 R Modulates D 1 R Function in Living Cells. To study how cocaine affects D 1 R-mediated signaling, CHO cells were used, as they provided a lower baseline of signaling for which to detect downstream changes. CHO cells were also shown to constitutively express σ 1 Rs but not DAT or D 1 Rs (Fig. 5 A  and B) . As expected, in CHO cells expressing D 1 Rs, the full D 1 R agonist SKF 81297 dose-dependently increased cAMP production (Fig. 5C ). Treatment with cocaine (150 μM; 10 min) did not induce a significant increase in cAMP, but robustly enhanced D 1 R agonist-induced cAMP accumulation (Fig. 5C ). This was completely counteracted by silencing expression of σ 1 R via RNAi (Fig. 5C ), indicating that this effect of cocaine was mediated by σ 1 R. SKF 81297 also produced a dose-dependent MAPK activation (ERK1/2 phosphorylation; Fig. 6A ) with a maximum response at 2 min (Fig. 6B) . SKF 81297-induced ERK1/2 phosphorylation was inhibited by the D 1 R antagonist SCH 23390 (10 μM) and also by the σ 1 R antagonist PD144.418 (1 μM; Figs. 6 A and B), indicating that σ 1 R modulates a D 1 R-mediated MAP kinase pathway in addition to the cAMP pathway. Bifactorial ANOVA of results of samples without or with siRNA transfection showed significant effect of SKF (P < 0.0001 and P < 0.001, respectively), but only in samples without siRNA transfection was there a highly significant effect of cocaine (***P < 0.0001, compared with samples with the same concentration of SKF 81297 and without RNAi transfection and in the absence of cocaine; Bonferroni post hoc tests). . ERK1/2 phosphorylation is represented as percentage over basal levels (100%). Results are a mean ± SEM of four independent experiments performed in duplicate. Bifactorial ANOVA showed a significant effect of SKF 81297 (P < 0.0001 in A and P < 0.001 in B), and Bonferroni post hoc tests showed a significant SCH 23390-mediated or PD144.418-mediated counteraction of the effect SKF 81297 (*P < 0.05 and ***P < 0.001, compared with control samples with the same concentration and exposure time of SKF 81297).
Importantly, cocaine per se dose-dependently (Fig. 7A) and time-dependently (Fig. 7B ) activated ERK1/2 phosphorylation. Again, this effect was mediated by σ 1 R, as it was strongly diminished in cells transfected with the σ 1 R siRNA (Fig. 7 A and  B) . Furthermore, a similar effect could be obtained with the selective σ 1 R agonist PRE084 (Fig. S1 ). Cocaine-induced ERK1/ 2 phosphorylation seemed to be dependent on D 1 R expression, because the increase in ERK1/2 phosphorylation was not found in CHO cells lacking D 1 R expression (Fig. S2) . Moreover, cocaine-induced ERK1/2 phosphorylation in cells expressing σ 1 R and D 1 R was not only counteracted by PD144.418 (1 μM), which therefore acted as a σ 1 R antagonist, but also by SCH 23390 (10 μM, Fig. 7 C and D) . All of these results suggest that cocaine binding to σ 1 R or SKF 81297 binding to D 1 R in the D 1 R-σ 1 R heteromer induce ERK1/2 phosphorylation that is equally counteracted by σ 1 R or D 1 R antagonists. Finally, we found a strong and reciprocal antagonistic interaction between σ 1 R and D 1 R on MAPK signaling. Thus, SKF 81297-induced ERK1/2 phosphorylation was drastically counteracted by increasing concentrations of cocaine (Fig. 8A) , and cocaine-induced ERK1/2 phosphorylation was also counteracted in the presence of increasing concentrations of SKF 81297 (Fig. 8B) . Again the same qualitative effects were obtained with the selective σ 1 R agonist PRE084 (Fig. S1 ).
Cocaine Binding to σ 1 R Modulates D 1 R Function in Mouse Brain
Striatum. To explore whether our results above using cultured cells could be extrapolated to the level of the organism, we took tissue from WT and s 1 R KO mice and examined the effects of cocaine on signaling. Previous in vivo studies have shown that pharmacologically significant doses of cocaine produce striatal levels of the drug at a low micromolar range (20) . Those measurements reflect free, rather than bound, concentrations of cocaine, and it is well established that higher drug concentrations need to be applied in brain slice preparations, to allow diffusion into the tissue. Because, in cotransfected CHO cells, a strong and significant effect of cocaine was observed at 30 μM (Fig. 8A) , a fivefold higher concentration, 150 μM, was then used to see clear effects in slices of mouse striatum (Fig. 8C) . On one hand, both the D 1 R agonist SKF 81297 (1 μM) and cocaine (150 μM) induced ERK1/2 phosphorylation in striatal slices of WT mice after 10-min activation (Fig. 8C) . On the other hand, in striatal slices of WT mice, SKF 81297-induced ERK1/2 phosphorylation was significantly reduced with pretreatment with cocaine for 30 min (Fig. 8C) . The antagonistic interaction between σ 1 R and D 1 R on MAPK signaling is therefore detected in cotransfected cells and in striatal samples from WT mice. When similar experiments were performed in striatal slices from mice lacking the σ 1 R, cocaine was unable to induce ERK1/2 phosphorylation (Fig. 8C) and SKF 81297-induced ERK1/2 phosphorylation was not modified by pretreatment with cocaine (Fig. 8C) . These results strongly support the existence of σ 1 R-D 1 R heteromers in Results are mean ± SEM of four to seven independent experiments performed in duplicate. In all samples, bifactorial ANOVA showed a significant (P < 0.0001 in A-C; P < 0.001 in D) effect of cocaine, and Bonferroni post hoc tests showed a significant counteraction of cocaine effect by siRNA (A and B, *P < 0.05 and **P < 0.01 compared with sample with the same treatment and without siRNA transfection) and a significant SCH 23390-mediated or PD144.418-mediated counteraction of the cocaine effect for some concentrations and exposure times (C and D, *P < 0.05, **P < 0.01, and ***P < 0.001 compared with control samples with the same treatment). Results are mean ± SEM of four independent experiments performed in duplicate. One-way ANOVA followed by Bonferroni post hoc tests showed a significant cocaine-mediated counteraction of SKF 81297 and a significant SKF 81297-mediated counteraction of cocaine-induced ERK1/2 phosphorylation (*P < 0.05, **P < 0.01, and ***P < 0.001 compared with control, without cocaine or SKF 81297 exposure). (C) WT (filled bars) and σ 1 R KO (open bars) mouse striatal slices were treated with SKF 81297 for 10 min, with cocaine for 30 min or with cocaine for 30 min and, during the last 10 min, the addition of SKF 81297. Immunoreactive bands from six slices obtained from five WT or five KO animals were quantified for each condition. Values represent mean ± SEM of percentage of phosphorylation relative to basal levels found in untreated slices. Significant differences respect to corresponding treatment in WT mouse slices were calculated by bifactorial ANOVA followed by post hoc Bonferroni tests (**P < 0.01). the brain and indicate that all detected cocaine effects are dependent on σ 1 R.
Discussion
The role of σ 1 R in cell-signaling is not well understood and its main endogenous ligand has not been identified (12, 15) . It has been suggested that σ 1 R may possess a constitutive biological activity, and that σ 1 R ligands may just be modulators of its innate activity (12) . The best-characterized acute effects of σ 1 R ligands at the cellular level are their ability to modulate the function of several ion channels (K + channels, NMDA receptors, IP3 receptors) (12) . In the present study a mechanism by which σ 1 R modulates the function of a G-protein-coupled receptor, the D 1 R, is reported. This modulation depends on protein-protein interactions, which were detected by BRET assays. In agreement with the oligomeric nature of D 1 R (18), the existence of heteromers constituted by a minimum of a D 1 R homodimer and a σ 1 R was demonstrated by BRET/BiFC.
The σ 1 R, which is found mainly at the membrane of the endoplasmic reticulum, may modulate the activity of plasma membrane-located ion channels by its ability to translocate to the plasma membrane (12, 21) . Coexpression of σ 1 R and D 1 R resulted in an alteration of σ 1 R subcellular distribution because, in the presence of D 1 R, σ 1 R was more abundant at the plasma membrane that in intracellular membranes. Importantly, coexpression of σ 1 R and D 1 R also led to heteromerization of the receptors, as measured by energy transfer in the absence of ligands. Acute administration of σ 1 R ligands, including cocaine, without coactivation of other receptors or channels may cause σ 1 R translocation to the plasma membrane (12) . Apart from the increase in plasma membrane σ 1 R expression, cocaine led to an increase of σ 1 R-D 1 R colocalization. Taken together, these data suggest that heteromerization occurs between these receptors at steady state in the absence of ligands, but the presence of cocaine might induce an increase of the amount of receptor heteromers constituted by σ 1 Rs and D 1 Rs homomers at the level of the plasma membrane, perhaps through some stabilization of a given receptor conformation.
Although further studies will be required to understand how cocaine acts on the receptor monomers, homomers or heteromers and the specific effects at a protein level, we were able to observe that cocaine binding to σ 1 R led to a structural modification, detected as a separation between the C termini of the D 1 Rs in the σ 1 R-D 1 R-D 1 R heterotrimer. This was evidenced by a pronounced decrease (Fig. 3C) in the BRET signal due to a decrease in the energy transfer between Rluc and YFP (located in the C-terminal domains of D 1 Rs). These structural changes, which did not result from dimer disruption, correlated with changes in D 1 R function, as demonstrated by means of assays performed in both heterologous cells and in slices from mouse striatum. Importantly, cocaine binding to σ 1 R robustly enhanced D 1 R agonist-induced cAMP accumulation. This synergy is probably underlying the predominant role of D 1 R versus D 2 R in the behavioral effects of cocaine (discussed earlier here). These results are also strong evidence that cocaine effects are not adequately addressed by assuming that the drug is just increasing the synaptic dopamine concentration by a DAT-dependent mechanism. In fact, the reported effects were not dependent on DAT, because cell lines lacking this protein were used. It is thus expected that cocaine is acting by at least two different but interrelated mechanisms, one dependent on DAT and leading to an increase in dopamine levels and another dependent on σ 1 R and leading to an enhancement of D 1 R-mediated neurotransmission.
Unexpectedly, cocaine was able to induce ERK1/2 phosphorylation per se, although this effect depended on the presence of both the D 1 R and σ 1 R. As these particular effects were reproduced by the selective σ 1 R agonist (17) and counteracted by the putative σ 1 R antagonist PD144.418 (22) , these results indicate that cocaine acts as a σ 1 R agonist. In living cells, cocaine-induced ERK1/2 phosphorylation was seen at short times of cocaine exposure (10 min); but the maximum effect was reached at 30 min, suggesting an involvement of cocaine-induced translocation of σ 1 R to the plasma membrane, with a consequent increase in cell surface σ 1 R-D 1 R heteromers. Both cocaineinduced and D 1 R-mediated ERK1/2 phosphorylation were counteracted by D 1 R or σ 1 R antagonists. The ability of an antagonist of one of the receptors in a receptor heteromer to block signals originated by stimulation of the partner receptor is a biochemical characteristic that has been described for other receptor heteromers, such as the D 1 R-histamine H 3 receptor heteromer (23) . Importantly, cocaine-induced ERK1/2 phosphorylation could also be demonstrated in mouse striatal slices, but not in striatal slices from σ 1 R KO mice. Because cocaineinduced ERK1/2 phosphorylation seems to be a biochemical characteristic of σ 1 R-D 1 R heteromers, these results provide evidence for the presence of these heteromers in the brain. Furthermore, we also found reciprocal antagonistic interactions between σ 1 R and D 1 R on MAPK activation, both in transfected cells and in mouse striatal slices. The D 1 R agonist-induced ERK1/ 2 phosphorylation was counteracted when agonist stimulation was performed in slices pretreated with cocaine and, conversely, cocaine-induced ERK1/2 phosporylation was counteracted by D 1 R agonist treatment. The cocaine-induced antagonistic modulation of D 1 R-mediated MAPK activation was shown to be dependent on σ 1 R, as demonstrated in cells transfected with σ 1 R siRNA and in striatal slices of σ 1 R KO mice. The qualitative similar results observed in transfected cells and in striatal slices support again the existence of σ 1 R-D 1 R heteromers in the brain.
We have described a previously uncharacterized mechanism by which cocaine binding to σ 1 R may significantly influence dopaminergic neurotransmission. Our results show that σ 1 R and D 1 R heteromerize in living cells and strongly suggest that σ 1 R-D 1 R heteromers are present in the striatum. Furthermore, our results shed light on the mechanisms behind the behavioral effects of cocaine that are dependent on σ 1 R. These data suggest that σ 1 R-D 1 R heteromers may be considered as targets for the treatment of cocaine addiction and that σ 1 R antagonists could counteract some of the behavioral and perhaps the addictive properties of cocaine. It will be important to determine the molecular determinants responsible for this heteromerization. This would allow the development of transgenic animals with mutated receptors not able to form σ 1 R-D 1 R receptor heteromers and therefore would allow one to better determine the role of σ 1 R-D 1 R receptor heteromerization in cocaine addiction.
Materials and Methods
Fusion Proteins and Expression Vectors. The N-terminal truncated (nYFP) and the C-terminal truncated (cYFP) version of YFP were made as previously indicated (24) . Human cDNAs for D 1 R, A 1 R, GABA B2 R, or σ 1 R cloned in pcDNA3.1 were amplified without their stop codons and subcloned in an Rluc-expressing vector (pRluc-N1; PerkinElmer), or in a variant of GFP (EYFP-N3; enhanced yellow variant of GFP; Clontech), to give the plasmids that express D 1 R, A 1 R, GABA B2 R or σ 1 R fused to either Rluc or YFP on the Cterminal end of the receptor (D 1 R-Rluc, D 1 R-YFP, σ 1 R-Rluc, σ 1 R-YFP, A 1 RRluc, A 1 R-YFP or GABA B2 R-Rluc). Human cDNA for D 1 R was subcloned in pcDNA3.1-cYFP or pcDNA3.1-nYFP to give the plasmids that express D 1 R fused to either nYFP or cYFP on the C-terminal end of the receptor (D 1 RcYFP and D 1 R-nYFP). When analyzed by confocal microscopy, it was observed that all fusion proteins showed similar subcellular distribution than naïve receptors. Fusion of Rluc and YFP to D 1 R did not modify receptor function as previously determined by cAMP assays.
Cell Culture and Transient Transfection. HEK-293T and CHO cells, grown as previously described (23, 24) , were transiently transfected with the corresponding cDNAs by PEI (PolyEthylenImine; Sigma) method as previously described (25) or with siRNA by lipofectamine (Invitrogen) method following the instructions of the supplier. Human and Chinese hamster σ 1 R siRNA and scrambled siRNA were designed and synthesized by Invitrogen (HSS 145543).
